$XL2CSOPHYNIX(07709.HK) Hang in there! Break-even is not far off. One thing this round of storage manufacturers did very well was exercising restraint in expanding capacity. No need to rush; humanity needs massive amounts of memory. Look at China's NEV market for proof.
Boss's Boss
$XTALPI(02228.HK) US AI biopharma stocks surged last night. Seeing the news this morning, Anthropic acquired an OPC—a single person working on biopharma, designing pipelines with AI assistance. Is this a tailwind or headwind for 2228? I lean towards bearish. From a compute perspective, China's AI pharma companies lag far behind the US in computational power, and the US still leads in using AI to understand the physical world, which has been my ongoing concern. If XtalPi continues to focus solely on its platform, it's in trouble. Fortunately, word is that 2228 will accelerate into pipeline development. Only by doing pharma directly and facing end consumers can you truly make big money. Torn, but I'll continue reducing my position in 2228. Even though profits dropped by a zero, I have to grit my teeth.
Summary of short positions on RKLB and TSLA
By Grok, based on the 'float ratio', RKLB is much more volatile than Tesla; in USD nominal terms, Tesla's short interest is larger...

